I1DX34:BVMF
Idexx Laboratories Inc Bdr
R$516.36
0.00%
(0.00) 1D
Oct 9, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for I1DX34...
Open
R$516.36
High
R$516.36
Low
R$516.36
Mkt. cap
40.81B
Avg. vol.
6.00
Volume
5.00
52-wk high
R$813.60
52-wk low
R$509.99
Shares outstanding
78.78M
No. of employees
11K
Open
R$516.36
High
R$516.36
Low
R$516.36
Mkt. cap
40.81B
Avg. vol.
6.00
Volume
5.00
52-wk high
R$813.60
52-wk low
R$509.99
Shares outstanding
78.78M
No. of employees
11K
News stories
From web sources and news partners
Simply Wall Street
·
27 minutes ago
Broadcom (AVGO) Is Leading A $50 Billion AI Chip Debt Push
The Globe and Mail
·
30 minutes ago
BTQ Technologies (NASDAQ: BTQ) (CBOE CA: BTQ) Named Security Partner for MoonPay Korea Stablecoin Infrastructure
Seeking Alpha
·
1 hour ago
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
About Idexx Laboratories Inc Bdr
CEOJay Mazelsky
Employees11K
FoundedDec 19, 1983
HeadquartersWestbrook, Maine, United States
SectorMedical device
Websiteidexx.com